Thank you very much, Mr. Chair.
As the chair pointed out, I am here as a witness because I represent a group of outstanding scientists from across the country. Our group wants Canada to play a larger role in global research and development because in the long term this research will produce societal and economic benefits for Canada.
Just to be clear, I am not speaking on behalf of my university or any of the universities where my colleagues work.
We also would like to point out that we do appreciate that the standing committee must have helped convince the government to increase R and D spending, particularly with respect to student scholarships, and we want to thank you for this leadership.
Although we were happy to see that R and D spending was going up, we, of course, wish to see the tri-council funded at least to the level the U15 asked for so that we could recover the loss from inflation that we have been suffering, but it's certainly a step in the right direction.
It is not just about the money, though. What we would also like to see is a scientific advisory group formed, as was mentioned in the budget. We would like the advisory group to be made up of leading Canadian scientists and innovators. Having such a committee of scientists advising the government is done in many countries.
President Biden has a President's Council of Advisors on Science and Technology, PCAST, made up of 30 of America's top researchers in science and technology. Frances Arnold, who won the Nobel Prize in chemistry the same year that I won the physics prize, has been one of the two external co-chairs of PCAST since 2021.
One of the key science questions the president has asked PCAST to answer is, how can we ensure the long-term health of science and technology in our nation? This is a question that our government also needs to be concerned about. Science should not be politicized. By its very nature, science has a long time horizon and does not fit into the short time scales of sitting governments and even less so into industries' quarterly and annual reports.
Other countries take the long view so that their children will be better off. My favourite example, as a few of you already know, is Korea, and not only because they spend almost 5% of their GDP on research and development. They do this not only because of military needs—as an aside, we too could build up our military spending by spending more on research—but also because they know that the country has reaped the economic benefits that this research has led to.
Korea has an intertwined system of support for research with government, academia and industry all playing equal roles, and then all benefiting equally from the participation.
Consider the example of Samsung. The Samsung company started back in the 1930s, almost 100 years ago, as a grocery store. Through government help and the obvious business savvy of the owner, that grocery store got into several other lines of trade. After the Korean War, the Korean government wanted Samsung to get into technology and gave them the funds through large tax breaks to start research in this emerging field.
When I first visited Seoul National University in 2011, I was taken to my colleague's optics lab in the tall, multi-storey Samsung building on the campus. My academic colleague was being well funded by Samsung, not to do research that would become a product in a year or two—that research and development was undoubtedly being done in Samsung's own research labs—but to work on futuristic holographic TVs, which we are still waiting for.
Samsung is now spending more money than the whole U.S. CHIPS act to make sure that Samsung can make the chips they will need in the future. Canada doesn't even have a CHIPS act. Where might that leave us? Right now, the chips are made in Taiwan.
We were left behind waiting for vaccines from other countries because we did not support our own biotech research from academia through to industry, so we had to wait until the other countries rightly made sure their own citizens were looked after first.
We want our government to follow best practices from other countries where government, industry and academia work well together and allow all three to benefit from the research. It doesn't have to be the Korean model. Denmark has tax laws about companies being owned by foundations, and these foundations have to support research. In 2023, I was hosted by the Novo Nordisk Foundation to give a public lecture at the Niels Bohr Institute of the University of Copenhagen, where the foundation had just announced the Novo Nordisk Foundation quantum computing program with funding of 1.5 billion Danish kroner, or about $200 million U.S.
A larger academic research entity is the Novo Nordisk Foundation Center for Protein Research, which was established back in 2007.
Last fall, it was announced that in a $500-million U.S. deal, the pharma giant Novo Nordisk, a company under the foundation, has acquired a University of Copenhagen spin-out, developing a novel therapeutic for obesity and type 2 diabetes. I watch commercials for this product on CNN all the time.